Deferoxamine for the diagnosis and treatment of aluminum-associated osteodystrophy.
Charhon
S
S
INSERM U. 234, Lyon, France.
el Yafi
S
S
Gaillard
M
M
Beruard
M
M
Janin
G
G
Accominotti
M
M
Traeger
J
J
Meunier
P J
PJ
D000328:Adult; D000535:Aluminum / Q000009:adverse effects* / Q000097:blood / Q000378:metabolism; D012080:Chronic Kidney Disease-Mineral and Bone Disorder / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology; D003676:Deferoxamine / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D010281:Parathyroid Hormone / Q000097:blood; D006435:Renal Dialysis / Q000009:adverse effects
D010281:Parathyroid Hormone; D000535:Aluminum; D003676:Deferoxamine